Oruka Therapeutics, Inc. — Form 4
Filed October 13, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 49/100
What the filing says
Senior Vice President, Finance Agarwal Arjun (ORKA) sold 20K shares (~$806K) on the open market (26% of holdings). Large sale — ~26% of holdings.
Why this rating
Large sale — ~26% of holdings.
See more from October 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.